Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice

Area of Science:

• Immunology
• Cellular Cytotoxicity
• Tumor Immunology

Background:

• Beta2-microglobulin (β2m) is crucial for Major Histocompatibility Complex (MHC) class I expression on cell surfaces.
• Mice deficient in β2m (B6.β2micro(o)) exhibit altered immune responses, particularly regarding cytotoxic activities against MHC class I-deficient targets.
• Understanding residual cytotoxic activities in these mice is key to dissecting immune surveillance mechanisms.

Purpose of the Study:

• To investigate residual cytotoxic activities in beta2-microglobulin-deficient mice.
• To assess the roles of Natural Killer (NK) cells and CD8(+) cytotoxic T lymphocytes (CTLs) reactive against self-MHC class I.
• To determine the involvement of perforin in these cytotoxic responses.

Main Methods:

• Utilized gene-targeted mice, including beta2-microglobulin-deficient (B6.β2micro(o)) and doubly deficient perforin/beta2-microglobulin (B6.P(o).β2micro(o)) strains.
• Assessed cytotoxic activities of NK cells and CD8(+) CTLs in vitro.
• Evaluated tumor rejection capabilities in vivo.

Main Results:

• Perforin deficiency abrogated cytotoxic activity in both NK cells and CD8(+) CTLs reactive against self-MHC class I.
• Demonstrated a critical dependence on perforin for in vitro cytotoxicity.
• Confirmed perforin's essential role in the in vivo rejection of various tumors by these effector cells.

Conclusions:

• Perforin is indispensable for the cytotoxic function of NK cells and CD8(+) CTLs targeting self-MHC class I.
• Perforin-mediated cytotoxicity is vital for tumor surveillance and rejection in the context of MHC class I deficiency.
• These findings highlight perforin as a key effector molecule in cellular immunity against tumors.